ODM derived from


Versions (4) ▾
  1. 12/9/13
  2. 4/11/14
  3. 4/11/14
  4. 4/13/21
Uploaded on:

April 13, 2021

No DOI assigned. To request one please log in.
Creative Commons BY 4.0
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Criteria NCT00071084


  1. StudyEvent: Eligibility
    1. Eligibility
Medical diagnosis of CTCL, and positivity for the CD4 receptor. - Late stage CTCL
Have received at least one prior anti-cancer therapy with inadequate effect
WHO performance status 0,1 or 2 - Male or female, age 18 or older. - Signed informed consent.
Certain rare types of CTCL.
Previous treatment with other anti-CD4 medications. - More than two previous treatments with systemic chemotherapy. - Certain anti-psoriasis or anti-cancer therapies within the last 4 weeks before entering this trial. - Some types of steroid treatments less than two weeks before entering the trial
Prolonged exposure to sunlight or UV light during the trial. - Other cancer diseases, except certain skin cancers or cervix cancer. - Chronic infectious disease requiring medication. - Certain serious medical conditions, including kidney or liver disease, some psychiatric illnesses, and stomach, lung, heart, hormonal, nerve or blood diseases. - Certain laboratory values which are too high or too low. - HIV positivity
Pregnant or breast-feeding women. - Women of childbearing age who are unable or unwilling to use an IUD or hormonal birth control during the whole trial
If you are participating in another trial with a different new drug 4 weeks before you enter this trial
Medical concepts

Similar models